Tag Archives: India’s First Gene Therapy Trial for Haemophilia Completed

India’s First Gene Therapy Trial for Haemophilia Completed

BRIC-inStem, based in Bengaluru, in collaboration with CMC Vellore, has successfully completed India’s inaugural human gene therapy trial for Haemophilia—a significant milestone in the country’s medical research. Understanding Gene Therapy Gene therapy is an advanced biomedical strategy aimed at correcting or replacing defective genes to treat or prevent diseases. Instead …

Read More »